Payments to Acquire Property, Plant, and Equipment of Prelude Therapeutics Inc from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Prelude Therapeutics Inc annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Prelude Therapeutics Inc Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $47,000, a 84% decline year-over-year.
  • Prelude Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2025 was $67,000, a 91% decline from 2024.
  • Prelude Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2024 was $764,000, a 78% decline from 2023.
  • Prelude Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3,513,000, a 16% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Prelude Therapeutics Inc Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $67,000 -$697,000 -91% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $764,000 -$2,749,000 -78% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $3,513,000 +$494,000 +16% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2025 2024 FY
2022 $3,019,000 +$696,000 +30% 01 Jan 2022 31 Dec 2022 10-K 15 Feb 2024 2023 FY
2021 $2,323,000 +$1,702,000 +274% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $621,000 -$159,000 -20% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $780,000 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY

Prelude Therapeutics Inc Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $47,000 -$242,000 -84% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $289,000 -$521,000 -64% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $810,000 -$142,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $952,000 -$34,000 -3.4% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $986,000 +$906,000 +1132% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $80,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.